NCT00454363 2020-04-03Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine CancerNational Cancer Institute (NCI)Phase 2 Completed52 enrolled 11 charts
NCT00131911 2014-11-17Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine TumorsNational Cancer Institute (NCI)Phase 2 Completed93 enrolled 10 charts